Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders

Yosiro Sawae; Yoshiyuki Niho; Takashi Okamura; Hisashi Gondo; Mitsuo Kozuru; Naokuni Uike; Koichiro Muta; Tatsuro Goto; Yoko Suehiro; Midori Kumakawa; Junji Nlshimura; Yuji Yufu; Hldeki Ishikura; Sayuri Yamashita; Syusuke Hisano; Em Morioka; Hiroaki Nakajima; Tsunefumi Shibuya; Kazuo Yamasaki; Naoki Harada; Ryokichi Asayama; Shin Hayashi; Kouichi Akashi; Eiichi Suematsu; Seiji Motomura; Yusei Yamamoto; Toru Takada; Kimiaki Ikeda; Fumihiro Taguchi; Yujiroh Yamano; Masako Taniouchi; Eijo Matsuishi; Yoshinobu Asano; Chiyuki Kawasaki

Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders

Yosiro Sawae, Yoshiyuki Niho, Takashi Okamura, Hisashi Gondo, Mitsuo Kozuru, Naokuni Uike, Koichiro Muta, Tatsuro Goto, Yoko Suehiro, Midori Kumakawa, Junji Nlshimura, Yuji Yufu, Hldeki Ishikura, Sayuri Yamashita, Syusuke Hisano, Em Morioka, Hiroaki Nakajima, Tsunefumi Shibuya, Kazuo Yamasaki, Naoki HaradaRyokichi Asayama, Shin Hayashi, Kouichi Akashi, Eiichi Suematsu, Seiji Motomura, Yusei Yamamoto, Toru Takada, Kimiaki Ikeda, Fumihiro Taguchi, Yujiroh Yamano, Masako Taniouchi, Eijo Matsuishi, Yoshinobu Asano, Chiyuki Kawasaki

Internal Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

One hundred and nine patients with infections concurrent with hematopoietic disorders were treated with imipenem/cilastatin sodium (IPM/CS) either alone (IPM/CS monotherapy) or in combination with other antimicrobial drugs (IPM/CS combination therapy). The following results were obtained.

Original language	English
Pages (from-to)	10-13
Number of pages	4
Journal	Japanese Journal of Antibiotics
Volume	49
Issue number	12
Publication status	Published - 1996

All Science Journal Classification (ASJC) codes

Microbiology (medical)
Pharmacology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Sawae, Y., Niho, Y., Okamura, T., Gondo, H., Kozuru, M., Uike, N., Muta, K., Goto, T., Suehiro, Y., Kumakawa, M., Nlshimura, J., Yufu, Y., Ishikura, H., Yamashita, S., Hisano, S., Morioka, E., Nakajima, H., Shibuya, T., Yamasaki, K., ... Kawasaki, C. (1996). Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders. Japanese Journal of Antibiotics, 49(12), 10-13.

Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders. / Sawae, Yosiro; Niho, Yoshiyuki; Okamura, Takashi et al.
In: Japanese Journal of Antibiotics, Vol. 49, No. 12, 1996, p. 10-13.

Research output: Contribution to journal › Article › peer-review

Sawae, Y, Niho, Y, Okamura, T, Gondo, H, Kozuru, M, Uike, N, Muta, K, Goto, T, Suehiro, Y, Kumakawa, M, Nlshimura, J, Yufu, Y, Ishikura, H, Yamashita, S, Hisano, S, Morioka, E, Nakajima, H, Shibuya, T, Yamasaki, K, Harada, N, Asayama, R, Hayashi, S, Akashi, K, Suematsu, E, Motomura, S, Yamamoto, Y, Takada, T, Ikeda, K, Taguchi, F, Yamano, Y, Taniouchi, M, Matsuishi, E, Asano, Y & Kawasaki, C 1996, 'Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders', Japanese Journal of Antibiotics, vol. 49, no. 12, pp. 10-13.

@article{f9666c17dade4332a4d1747f9245fd34,

title = "Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders",

abstract = "One hundred and nine patients with infections concurrent with hematopoietic disorders were treated with imipenem/cilastatin sodium (IPM/CS) either alone (IPM/CS monotherapy) or in combination with other antimicrobial drugs (IPM/CS combination therapy). The following results were obtained.",

author = "Yosiro Sawae and Yoshiyuki Niho and Takashi Okamura and Hisashi Gondo and Mitsuo Kozuru and Naokuni Uike and Koichiro Muta and Tatsuro Goto and Yoko Suehiro and Midori Kumakawa and Junji Nlshimura and Yuji Yufu and Hldeki Ishikura and Sayuri Yamashita and Syusuke Hisano and Em Morioka and Hiroaki Nakajima and Tsunefumi Shibuya and Kazuo Yamasaki and Naoki Harada and Ryokichi Asayama and Shin Hayashi and Kouichi Akashi and Eiichi Suematsu and Seiji Motomura and Yusei Yamamoto and Toru Takada and Kimiaki Ikeda and Fumihiro Taguchi and Yujiroh Yamano and Masako Taniouchi and Eijo Matsuishi and Yoshinobu Asano and Chiyuki Kawasaki",

year = "1996",

language = "English",

volume = "49",

pages = "10--13",

journal = "Japanese Journal of Antibiotics",

issn = "0368-2781",

publisher = "Japan Antibiotics Research Association",

number = "12",

}

TY - JOUR

T1 - Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders

AU - Sawae, Yosiro

AU - Niho, Yoshiyuki

AU - Okamura, Takashi

AU - Gondo, Hisashi

AU - Kozuru, Mitsuo

AU - Uike, Naokuni

AU - Muta, Koichiro

AU - Goto, Tatsuro

AU - Suehiro, Yoko

AU - Kumakawa, Midori

AU - Nlshimura, Junji

AU - Yufu, Yuji

AU - Ishikura, Hldeki

AU - Yamashita, Sayuri

AU - Hisano, Syusuke

AU - Morioka, Em

AU - Nakajima, Hiroaki

AU - Shibuya, Tsunefumi

AU - Yamasaki, Kazuo

AU - Harada, Naoki

AU - Asayama, Ryokichi

AU - Hayashi, Shin

AU - Akashi, Kouichi

AU - Suematsu, Eiichi

AU - Motomura, Seiji

AU - Yamamoto, Yusei

AU - Takada, Toru

AU - Ikeda, Kimiaki

AU - Taguchi, Fumihiro

AU - Yamano, Yujiroh

AU - Taniouchi, Masako

AU - Matsuishi, Eijo

AU - Asano, Yoshinobu

AU - Kawasaki, Chiyuki

PY - 1996

Y1 - 1996

N2 - One hundred and nine patients with infections concurrent with hematopoietic disorders were treated with imipenem/cilastatin sodium (IPM/CS) either alone (IPM/CS monotherapy) or in combination with other antimicrobial drugs (IPM/CS combination therapy). The following results were obtained.

AB - One hundred and nine patients with infections concurrent with hematopoietic disorders were treated with imipenem/cilastatin sodium (IPM/CS) either alone (IPM/CS monotherapy) or in combination with other antimicrobial drugs (IPM/CS combination therapy). The following results were obtained.

UR - http://www.scopus.com/inward/record.url?scp=33749268994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749268994&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749268994

SN - 0368-2781

VL - 49

SP - 10

EP - 13

JO - Japanese Journal of Antibiotics

JF - Japanese Journal of Antibiotics

IS - 12

ER -

Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Fingerprint

Cite this